scholarly journals Earlier Initiation of Community-Based Palliative Care Is Associated With Fewer Unplanned Hospitalizations and Emergency Department Presentations in the Final Months of Life: A Population-Based Study Among Cancer Decedents

2018 ◽  
Vol 55 (3) ◽  
pp. 745-754.e8 ◽  
Author(s):  
Cameron M. Wright ◽  
David Youens ◽  
Rachael E. Moorin

Author(s):  
Chanel Kwok ◽  
Yvonne DeWit ◽  
Jennifer Olajos-Clow ◽  
Carole Madeley ◽  
Mona Jabbour ◽  
...  


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
N. Ahmad Aziz ◽  
Victor M. Corman ◽  
Antje K. C. Echterhoff ◽  
Marcel A. Müller ◽  
Anja Richter ◽  
...  

AbstractTo estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing community-based cohort study in Bonn, Germany. We first assessed anti-SARS-CoV-2 immunoglobulin G levels with an immunoassay, followed by confirmatory testing of borderline and positive test results with a recombinant spike-based immunofluorescence assay and a plaque reduction neutralization test (PRNT). Those with a borderline or positive immunoassay result were retested after 4 to 5 months. At baseline, 4771 persons participated (88% response rate). Between April 24th and June 30th, 2020, seroprevalence was 0.97% (95% CI: 0.72−1.30) by immunoassay and 0.36% (95% CI: 0.21−0.61) when considering only those with two additional positive confirmatory tests. Importantly, about 20% of PRNT+ individuals lost their neutralizing antibodies within five months. Here, we show that neutralizing antibodies are detectable in only one third of those with a positive immunoassay result, and wane relatively quickly.



2018 ◽  
Vol 6 (6) ◽  
pp. 1907-1913.e4 ◽  
Author(s):  
Teresa To ◽  
Jingqin Zhu ◽  
Kandace Ryckman ◽  
Andrea Gershon




2009 ◽  
Vol 49 (1) ◽  
pp. 21-30 ◽  
Author(s):  
Benjamin W. Friedman ◽  
Daniel Serrano ◽  
Michael Reed ◽  
Merle Diamond ◽  
Richard B. Lipton


Sign in / Sign up

Export Citation Format

Share Document